Intrinsic Value of S&P & Nasdaq Contact Us

Terns Pharmaceuticals, Inc. TERN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
46/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$55.67
+5.7%

Terns Pharmaceuticals, Inc. (TERN) has 9 identified peers for comparison in the Healthcare sector. Peers include ABOS, AMLX, DAWN, ELDN, HOOK, INZY and others.

TERN has a market capitalization of $4.75B, compared to an average peer market cap of $489.92M. TERN is significantly larger than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message